Antiviral Drugs for Cirrhosis and Hepatitis

Viruses are the intracellular parasites that depend on synthetic processes of host cells. They cannot be grown on ordinary medium. Special microscopes are needed to visualize their structure, which consists of Genome (genetic material consisting of DNA or RNA component but never both), Surrounding capsid –proteinaceous in structure, Envelope –protein bilayer. Hepatitis B virus (HBV) is an important cause of end-stage liver disease and hepatocellular carcinoma (HCC). The decision to treat is based on the activity of liver disease and HBV replication status, and the likelihood of a long-term benefit. Approved therapies include standard and pegylated interferon-alfa and nucleoside analogues: lamivudine, adefovir and entecavir. Even with successful therapy, patients remain at risk for reactivation of viral replication and require lifelong monitoring.

HBV in HBsAg-positive patients treated with allogeneic hematopoietic cell transplantation. Highly active antiretroviral therapy is initiated for decreasing mortality relating to HIV. Influenza can be type A, B or C depending upon type. Influenza A and B are more common.

  • Anti-retroviral agents
  • Antiviral Regimens
  • Anti-herpes virus agents
  • Anti influenza agents

Related Conference of Antiviral Drugs for Cirrhosis and Hepatitis

May 26-26, 2021

International Conference on Hepatitis

London, UK
June 14-15, 2021

7th International Conference on Hepatology

Osaka, Japan
June 14-15, 2021

International Conference on Gastroenterology and Liver

Amsterdam, Netherlands
June 14-15, 2021

International Congress on Viral Hepatitis

Rome, Italy
July 13-14, 2021

International Conference on Hepatitis & Liver diseases

Shanghai, Australia
July 20-21, 2021

20th World Gastroenterologists Summit

Osaka, Japan
August 05-06, 2021

Global Congress on Pancreas

Zurich, Switzerland
September 27-28, 2021

8th Global Conference on Mass Spectrometry

Tokyo, Japan
September 28-29, 2021

2 nd World Congress on Oil and Gas Engineering

Auckland, Newzealand
November 23-24, 2021

World Conference on Digestive and metabolic diseases

Hanoi, Vietnam

Antiviral Drugs for Cirrhosis and Hepatitis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in